ENDV

1 stories · following the connections

Business

Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients

By Nasdaq OMXMay 1, 2018, 11:35 AM UTC